Загрузка...
Subconjunctival sirolimus in the treatment of diabetic macular edema
BACKGROUND: Diabetic macular edema (DME) is a leading cause of blindness in the developed world. Sirolimus has been shown to inhibit the production, signaling, and activity of many growth factors relevant to the development of diabetic retinopathy. This phase I/II study assesses the safety of multip...
Сохранить в:
| Главные авторы: | , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2011
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3183290/ https://ncbi.nlm.nih.gov/pubmed/21567211 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00417-011-1694-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|